Moneycontrol Bureau
Opto Circuits shares rallied as much as 6 percent intraday on Thursday after its group company received approval from the US Food and Drug Administration (USFDA) for AED.
"Cardiac Science Corporation, a group company of Opto Circuits, has received 510(k) market clearance for Powerheart G5 AED from the USFDA," the company said in its filing.
Cardiac Science is a global leader in automated external defibrillators (AEDs).
This approval allows the company to begin selling the AED later this year along with its successful Powerheart® G3 product line.
The company said the Powerheart family of AEDs is designed to enable rescuers to swifty provide effective, life-saving therapy to aid a person who has suffered sudden cardiac arrest (a condition in which the heart suddenly stops beating due to irregularities in its electrical system).
"The Powerheart G5 will be available for purchase in the United States later this year," the medical equipment manufacturer said.
Opto Circuits India stock closed at Rs 26.10, up 3.57 percent on the Bombay Stock Exchange.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
